Glow-in-the-Dark dye helps surgeons spot hidden lung cancer

NCT ID NCT06145048

Completed Diagnosis Sponsor: Vergent Bioscience, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a special fluorescent dye called VGT-309 that makes lung cancer cells glow during surgery. About 89 people with known or suspected lung cancer received the dye before their operation. The goal was to see if the dye helps surgeons find tumors that are hard to see with standard methods, including small or hidden cancer spots and cancerous lymph nodes. The dye is not a treatment itself but a tool to improve surgical accuracy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER LUNG METASTASES

Contacts and locations

Locations

City of Hope National Medical Center

Duarte, California, 91010, United States
Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States
Mayo Clinic

Rochester, Minnesota, 55905, United States
Orlando Health Cancer Institute

Orlando, Florida, 32806, United States
St. Vincent's Hospital

Melbourne, Victoria, 3065, Australia
University of Texas MD Anderson Cancer Center

Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.